Zartan Co 50 mg/100 mg FC tablets

Zartan Co 50 mg/100 mg FC tablets

S3
PDF Leaflet Revision Date: 27 September 2024


Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of hypertension.

Dosage (summary)

Start with 50/12.5 mg once daily; may increase to 100/25 mg if needed.

Onset of Action / Duration

Onset: 3 weeks, Duration: 24 hours

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation.

Key Drug Interactions

  • NSAIDs
  • Lithium
  • Potassium-sparing diuretics

Contraindications

  • Hypersensitivity
  • Severe renal impairment
  • Severe hepatic impairment
  • Pregnancy
  • Lactation

Common side effects

  • Dizziness
  • Hypotension
  • Hyperkalaemia
  • Fatigue

Counselling Points

  • Monitor blood pressure regularly
  • Avoid potassium supplements
  • Report any skin changes

Serious warnings

  • Risk of fetal injury
  • Dual blockade of RAAS not recommended
Important Disclaimer

The Zartan Co 50 mg/100 mg FC tablets professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites